PMID: 322491Apr 15, 1977Paper

The treatment of dysmenorrhea with naproxen sodium: a report on two independent double-blind trials

American Journal of Obstetrics and Gynecology
M R HenzlS Bessler

Abstract

The efficacy of naproxen sodium (naproxen-Na) in dysmenorrhea has been established in two independent double-blind (placebo-controlled) studies. An initial dose of 550 mg. of naproxen-Na was followed by 275 mg. every six hours for a maximum of five days. Twenty patients were included in Study I (10 treated with naproxen-Na) and 23 patients in Study II (12 treated with naproxen-Na). Each patient received the medication during four dysmenorrheic episodes. Thus, a total of 172 treatment courses could be evaluated. A variety of efficacy criteria were measured: frequency of pill intake, changes in pain intensity, the degree of relief achieved by the medication, and need for additional analgesics. In both studies naproxen-Na was demonstrated to be superior to the placebo treatment with high statistical significance in each of these parameters.

Citations

Jan 1, 1980·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·G A Kintis, B Coutifaris
Jan 1, 1984·Drug Intelligence & Clinical Pharmacy·N J Wenzloff, L Shimp
Apr 1, 1980·British Journal of Obstetrics and Gynaecology·J R Pogmore, G M Filshie
Jun 1, 1980·British Journal of Clinical Pharmacology·U R KrishnaU K Sheth
Aug 1, 1979·British Journal of Obstetrics and Gynaecology·M G Elder, L Kapadia
Nov 1, 1979·The Australian & New Zealand Journal of Obstetrics & Gynaecology·C WoodR Williams
Feb 1, 1978·British Journal of Obstetrics and Gynaecology·K E Andersson, U Ulmsten
Dec 18, 1978·European Journal of Clinical Pharmacology·T JanbuB I Nesheim
Nov 1, 1984·British Journal of Obstetrics and Gynaecology·I Milsom, B Andersch
Jan 1, 1980·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·A J Davies
Aug 6, 1998·British Journal of Obstetrics and Gynaecology·W Y Zhang, A Li Wan Po
Jul 2, 2015·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Omid R ZekavatFarzaneh Alipour
Aug 1, 1979·Archives of Gynecology·B SandahlK E Andersson
Jan 1, 1978·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·H A SandeA Izu
Feb 22, 1978·Archiv für Gynäkologie·P Kajanoja
Aug 1, 2015·The Cochrane Database of Systematic Reviews·Jane MarjoribanksMichelle Proctor
Feb 1, 1981·Prostaglandins and Medicine·O YlikorkalaA Kauppila

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics
H A SandeA Izu
The Journal of Reproductive Medicine
S L Corson, R J Bolognese
© 2021 Meta ULC. All rights reserved